跳到正文
原文
Medical Xpress·· 25 天前精选AI 评分71

小细胞肺癌中发现代谢脆弱性

Metabolic vulnerability identified in small cell lung cancer

AI 导读

研究人员发现小细胞肺癌在缺乏半胱氨酸时,不同细胞状态通过不同机制死亡,ASCL1蛋白可保护某些肿瘤细胞免受铁死亡。该研究为开发针对共同代谢依赖性的新疗法提供了潜在靶点。

推荐理由

揭示了小细胞肺癌不同细胞状态对代谢压力的不同反应机制,为开发新疗法提供了潜在靶点。

正文
Metabolic vulnerability identified in small cell lung cancer
Graphical abstract. Credit: Cell (2026). DOI: 10.1016/j.cell.2026.09.045

Researchers at the University of Cologne have demonstrated that, while various cellular states of small cell lung cancer are equally dependent on the amino acid cysteine, they react differently when deprived of it. While some cancer cells subsequently die via ferroptosis—a form of cell death in which harmful oxidized fats accumulate in the cell membranes—others undergo apoptosis, a controlled, programmed form of cell death.

In a new study, the researchers also identified a molecular mechanism that protects certain tumor cells from ferroptosis and that could potentially be targeted for therapeutic purposes. The study is published under the title "Cell-state-specific metabolic networks govern ferroptosis versus apoptosis in small cell lung cancer" in the journal Cell.

Tracing metabolism across tumor cell states

Small cell lung cancer is a particularly aggressive form of lung cancer, which is often not diagnosed until it has reached an advanced stage and is difficult to treat. One particular challenge is the high adaptability of tumor cells. They can alter their cellular state and, in doing so, also adapt their metabolism. This enables them to adjust to changing conditions and, in some cases, to evade treatment.

This led the researchers to investigate how the tumor's various cellular states differ in terms of their metabolism, and how these differences determine the cancer cells' response to metabolic stress. For this purpose, they combined various methods for investigating gene activity and cellular metabolism.

Using transcriptomics, they analyzed the entire set of mRNA molecules and were thus able to draw conclusions about the activity of individual genes. They also analyzed the full range of metabolic products in the cells and used metabolic tracing to track the path of specific nutrients through the metabolic pathways of the cancer cells.

The studies were carried out in cell culture, animal models and tumor models derived from patients.

ASCL1 activates a defense against ferroptosis

"Our research shows that all forms of small cell lung cancer studied are dependent on cysteine. If the cancer cells are deprived of cysteine, all the cancer cells die. However, it is the cell's state, governed by a regulatory protein, that determines how this happens," explains Dr. Silvia von Karstedt from the Department of Translational Genomics and the Center for Molecular Medicine Cologne (CMMC) at the University of Cologne, co-senior author of the study.

"Cells with low levels of the cell-state-regulating protein ASCL1 die by ferroptosis. Cells with high levels of ASCL1, on the other hand, can prevent this process, making them more resistant. We were able to show that ASCL1 activates the GCH1 gene in this process.

"This promotes the production of antioxidants, which protect the cells from harmful oxidative damage. If this protective mechanism is also blocked in addition to cysteine, tumor growth can be significantly slowed down in preclinical models."

Targeting a shared dependence on cysteine

Cancerous tumors consist of different cell populations, which may respond differently to treatment. At the same time, the cells can alter their state and thereby develop new survival strategies.

"Our findings show that this diversity also conceals a common weakness: this dependence on cysteine is observed in various cellular states. If we can successfully exploit this mutual dependence while simultaneously blocking the tumor cells' various defense mechanisms, this could be a new strategy for preventing the survival of cancer cells," said von Karstedt.

The preclinical study thus demonstrates how closely the adaptability of tumor cells is linked to their metabolism and their ability to survive under stress.

The results also provide a potential starting point for the development of new therapeutic strategies. In further studies, the researchers aim to characterize the identified protective mechanisms in greater detail and to investigate how these can be specifically and therapeutically influenced.

Publication details

Jun W. Kim et al., Cell-state-specific metabolic networks govern ferroptosis versus apoptosis in small cell lung cancer, Cell (2026). DOI: 10.1016/j.cell.2026.09.045

Journal information: Cell

Who's behind this story?

Sadie Harley

Sadie Harley

BSc Life Sciences & Ecology. Microbiology lab background with pharmaceutical news experience in oil, gas, and renewable industries. Full profile →

Robert Egan

Robert Egan

Bachelor's in mathematical biology, Master's in creative writing. Well-traveled with unique perspectives on science and language. Full profile →

Citation: Metabolic vulnerability identified in small cell lung cancer (2026, October 26) retrieved 26 October 2026 from https://medicalxpress.com/news/2026-10-metabolic-vulnerability-small-cell-lung.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

来源:Medical Xpress · medicalxpress.com